Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May not Persist to One Year

Tal Hasin, Avishay Grupper, John J. Dillon, Joseph Maleszewski, Zhuo Li, Yan Topilsky, Robert Frantz, Brooks Sayre Edwards, Naveen Luke Pereira, Simon Maltais, John M. Stulak, Lyle Joyce, Richard Daly, Soon J. Park, Sudhir S. Kushwaha

Research output: Contribution to journalArticle

3 Scopus citations


Renal function improves early after left ventricular assist device (LVAD) implantation but later decline has been observed. We sought to determine the occurrence and evaluate possible causes for this decline. In 62 consecutive patients with HeartMateII LVAD with available calculated glomerular filtration rate (GFR, ml/min/1.73m) one year after implant, GFR was assessed repeatedly and possible predictors for decline from 3 to 12 months were investigated. Post-mortem renal specimens for patients supported with an LVAD were evaluated. GFR at admission (54.5±19.5), increased to 66.4±22.3 pre-operatively and to 79.2±30.1 ~one month after implantation. Subsequently at ~3 months GFR declined to 74.7±25.4, at ~6 months to 68.8±23.1 and ~1 year after implant to 63.9±17.7. GFR at 1 year was significantly lower (p<0.0001, p<0.0001, p=0.005) than GFR 1, 3 and 6 months after implant. Early rise in GFR after surgery was not associated with late decline. Shorter bypass time (β=-0.09, p=0.048) and higher albumin 3 months after LVAD (β=14.4, p=0.025) were significantly associated with less later decline in GFR. Arteriosclerosis was identified in autopsy renal specimens.In conclusion, early gains in renal function after LVAD implant are not sustained in many patients. Patient, device and operative factors may influence long-term renal function in these patients.

Original languageEnglish (US)
JournalASAIO Journal
StateAccepted/In press - Jan 19 2017


ASJC Scopus subject areas

  • Bioengineering
  • Biophysics
  • Medicine(all)
  • Biomaterials
  • Biomedical Engineering

Cite this